Australia markets open in 6 hours 54 minutes

Takeda Pharmaceutical Company Limited (TKPHF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
26.62+0.56 (+2.15%)
As of 09:49AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 41.68B
Enterprise value 69.48B
Trailing P/E 36.66
Forward P/E 23.26
PEG ratio (5-yr expected) 3.26
Price/sales (ttm)1.56
Price/book (mrq)0.96
Enterprise value/revenue 0.02
Enterprise value/EBITDA 0.07

Trading information

Stock price history

Beta (5Y monthly) 0.54
52-week change 3-21.17%
S&P500 52-week change 323.10%
52-week high 334.47
52-week low 325.04
50-day moving average 327.73
200-day moving average 328.90

Share statistics

Avg vol (3-month) 36.09k
Avg vol (10-day) 3340
Shares outstanding 51.57B
Implied shares outstanding 61.6B
Float 81.55B
% held by insiders 10.03%
% held by institutions 144.73%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.24
Forward annual dividend yield 44.77%
Trailing annual dividend rate 3184.00
Trailing annual dividend yield 3706.20%
5-year average dividend yield 44.58
Payout ratio 4163.61%
Dividend date 328 June 2010
Ex-dividend date 428 Mar 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in JPY.

Fiscal year

Fiscal year ends 31 Mar 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 4.28%
Operating margin (ttm)9.44%

Management effectiveness

Return on assets (ttm)2.61%
Return on equity (ttm)2.76%

Income statement

Revenue (ttm)4.17T
Revenue per share (ttm)2,670.94
Quarterly revenue growth (yoy)1.30%
Gross profit (ttm)N/A
EBITDA 1.21T
Net income avi to common (ttm)178.22B
Diluted EPS (ttm)0.71
Quarterly earnings growth (yoy)-11.30%

Balance sheet

Total cash (mrq)288.36B
Total cash per share (mrq)183.79
Total debt (mrq)5.21T
Total debt/equity (mrq)77.21%
Current ratio (mrq)1.06
Book value per share (mrq)4,297.21

Cash flow statement

Operating cash flow (ttm)731.45B
Levered free cash flow (ttm)-9.88B